Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11034729 Respiratory syncytial virus (RSV) vaccine

Patent 11034729 was granted and assigned to CureVac on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
CureVac
CureVac
0
Date Filed
October 23, 2018
0
Date of Patent
June 15, 2021
0
Patent Applicant
CureVac
CureVac
0
Patent Application Number
16168747
0
Patent Citations
‌
US Patent 10150797 Respiratory syncytial virus (RSV) vaccine
0
Patent Citations Received
‌
US Patent 12109275 Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
0
‌
US Patent 11760992 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
‌
US Patent 11761009 Artificial nucleic acid molecules for improved protein expression
‌
US Patent 11786590 Rotavirus vaccines
‌
US Patent 11834651 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
0
‌
US Patent 11865084 MERS coronavirus vaccine
0
‌
US Patent 11965000 Respiratory syncytial virus (RSV) vaccine
0
‌
US Patent 12083190 Rabies vaccine
0
‌
US Patent 11661634 Method for producing RNA
0
‌
US Patent 11667910 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
0
Patent Inventor Names
Margit Schnee
0
Daniel Voss
0
Thomas Kramps
0
Benjamin Petsch
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11034729
0
Patent Primary Examiner
‌
Agnieszka Boesen
0

Find more entities like US Patent 11034729 Respiratory syncytial virus (RSV) vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo